These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Liver dysfunction syndrome during kidney cancer]. Niquet G; Lhermine C; Dehaene P; Defrance G; Dupuich Y Lille Med; 1978 Dec; 23(10):709-13. PubMed ID: 748706 [No Abstract] [Full Text] [Related]
6. [Reversible disorders of hepatic function in cancer of the kidney]. Cachin M; Lévy C; Monnier JP Sem Hop; 1970 Mar; 46(12):814-6. PubMed ID: 4317081 [No Abstract] [Full Text] [Related]
7. Humoral syndromes of renal adenocarcinoma in man. Sufrin G; Murphy GP Rev Surg; 1977; 34(3):149-66. PubMed ID: 325636 [No Abstract] [Full Text] [Related]
9. [Reversible liver dysfunction in patients with cancer of the kidney]. Pytel' AIa Urol Nefrol (Mosk); 1973; 38(1):13-8. PubMed ID: 4348377 [No Abstract] [Full Text] [Related]
10. The nonmetastatic hepatic dysfunction syndrome associated with renal cell carcinoma (hypernephroma): Stauffer's syndrome. Hanash KA Prog Clin Biol Res; 1982; 100():301-16. PubMed ID: 7145952 [No Abstract] [Full Text] [Related]
11. [The pathological breakdown of the two-color dye tests in participation of the liver in non-liver disease occurrences]. Bargon G; Hochmiller C Acta Hepatosplenol; 1966; 13(4):201-7. PubMed ID: 5987791 [No Abstract] [Full Text] [Related]
12. Hepatic dysfunction and fever associated with hypernephroma. Tartaglia AP; Wolfe S; Propp S N Y State J Med; 1970 Sep; 70(17):2231-4. PubMed ID: 5273004 [No Abstract] [Full Text] [Related]
13. [Renal dysfunction in liver diseases]. Rychalska-Glanc B Przegl Epidemiol; 1975; 29(2):229-33. PubMed ID: 1096246 [No Abstract] [Full Text] [Related]
14. [Evaluation of liver function in liver diseases using drugs as indicators]. Tanaka E; Yasuhara H J Toxicol Sci; 1997 Aug; 22(3):APP 79-87. PubMed ID: 9379499 [No Abstract] [Full Text] [Related]
15. Stauffer's syndrome--diagnostic help in hypernephroma. Jacobi GH; Philipp T Clin Nephrol; 1975; 4(3):113-5. PubMed ID: 1183098 [TBL] [Abstract][Full Text] [Related]
16. [Measurement of hepatic function and short-term prognosis of hepatic diseases]. Rueff B Gastroenterol Clin Biol; 1985 Dec; 9(12):867-70. PubMed ID: 3830799 [No Abstract] [Full Text] [Related]
17. [A case of a malignant kidney tumor with the nephrogenic liver dysfunction syndrome]. Kochetova EV; Ignat'ev VK; Fliugrant TF Klin Med (Mosk); 1995; 73(3):102-3. PubMed ID: 8577090 [No Abstract] [Full Text] [Related]
18. [Study and evaluation of liver function with anatomopathological control]. Leno Valencia L; Matorras Galán P; Ramos Fernández R; Terán Díaz E; Val Bernal F; Garijo Ayensa F; Vidal Sampedro E Rev Clin Esp; 1971 Nov; 123(4):335-40. PubMed ID: 5157915 [No Abstract] [Full Text] [Related]
19. [Hepatic and renal elimation of bromsulphalein in chronic hepatitis, post-inflammatory cirrhosis and obstructive jaundice]. Babiuch L Przegl Epidemiol; 1975; 29(2):159-67. PubMed ID: 1144806 [No Abstract] [Full Text] [Related]
20. THE HEPATOPATHY OF HYPERNEPHROMA. LEMMON WT; HOLLAND PV; HOLLAND JM Am J Surg; 1965 Sep; 110():487-91. PubMed ID: 14338014 [No Abstract] [Full Text] [Related] [Next] [New Search]